Search

A new perspective piece highlights how phages, phage-derived proteins and organic acids offer potential as biocontrols for fruit crop pathogens (especially P. syringae pathovars actinidiae and syringae, which attack kiwifruit and stone frui

David Harper discusses the complexities and limitations of using phages as therapeutics in his recent LinkedIn post, emphasizing the challenges posed by the immune system and the size of phages compared to conventional antibiotics.

In a new GARDP antimicrobial viewpoint piece, Jon Iredell and Jessica Sacher of Phage Australia discuss ways to improve the economics of personalized phage therapy as part of a clinical service, including increasing the number of patients w

In a new opinion piece in the Boston Globe, Kevin Outterson and Henry Skinner discuss the global threat of antibiotic resistance.

In this opinion piece for USA Today, Mallory Smith's mother, Diane Shader Smith, describes her daughter's preventable death from a drug resistant infection, and reflects on the opportunity that currently exists for US Congress to pass the P

Opinion: Diversity in the soil virosphere: to infinity and beyond? Read author Simon Roux’s Twitter thread on this report!

Opinion piece: Can bacteriophages replace antibiotics?

Stephen Abedon (Ohio State University, USA) and colleagues published an opinion article in Viruses on improving phage-biofilm in vitro experimentation. They discuss current issues and suggest improvements in the design, interpretation and r

Interested in how phages could be useful in the COVID-19 battle? Here are a couple of opinions on this: one by Marcin Wojewodzic (Cancer Registry of Norway), published in PHAGE journal, and one by health and science journalist Helen Albert,

An interesting reflection by Prof. Marc Bonten of UMC Utrecht on the current impasse in the Netherlands when it comes to the need for phage clinical trials, and on UMCU's recent discussions with national health authorities on the matter.

An interesting reflection by Prof. Marc Bonten of UMC Utrecht on the current impasse in the Netherlands when it comes to the need for phage clinical trials, and on UMCU's recent discussions with national health authorities on the matter.

Our opinion piece, A Bright Outlook for Bacteriophage Applications, is featured in the Microbiome Times January 2019 edition (page 34).

Check out our new paper on sourcing phages for compassionate use, which was published in the journal Microbiology Australia last week!

Karin Moelling et al. published a paper this week in Viruses calling for urgent changes in regulation to allow phage therapy to proceed for patients in need. The authors are also championing a petition for the cause — learn more at http://p

The dairy industry has historically seen phages as a threat to productions, but Samuel D. Alcaine, a Cornell professor researching dairy fermentations, makes the point here that phages could also be beneficial to the industry.

Check out our new paper on sourcing phages for compassionate use, which was published in the journal Microbiology Australia last week!

Our opinion piece, A Bright Outlook for Bacteriophage Applications, is featured in the Microbiome Times January 2019 edition (page 34).

The dairy industry has historically seen phages as a threat to productions, but Samuel D. Alcaine, a Cornell professor researching dairy fermentations, makes the point here that phages could also be beneficial to the industry.

Karin Moelling et al. published a paper this week in Viruses calling for urgent changes in regulation to allow phage therapy to proceed for patients in need. The authors are also championing a petition for the cause — learn more at http://p